Status:
COMPLETED
Whole Exome Sequencing in Coronary Artery Ectasia
Lead Sponsor:
Jagiellonian University
Collaborating Sponsors:
Medical University of Warsaw
Poznan University of Medical Sciences
Conditions:
Coronary Ectasia
Coronary Aneurysm
Eligibility:
All Genders
18-80 years
Brief Summary
The goal of this observational study is to assess the role of the whole exome sequencing (WES) application in patients with giant coronary artery ectasia (CAE) with a high-risk of genetic background. ...
Detailed Description
Coronary artery aneurysm and ectasia (CAAE) is defined as a dilation of the coronary artery by at least 1.5 times compared to the adjacent segment. The incidence of CAAE is reported in 0.3-5.3% of pat...
Eligibility Criteria
Inclusion
- diagnosed giant coronary artery aneurysm and ectasia (CAAE)
- high risk of genetic background
Exclusion
- the lack of informed consent for whole exome sequencing (WES) analysis
Key Trial Info
Start Date :
March 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT06001957
Start Date
March 23 2022
End Date
August 15 2023
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow, Jagiellonian University Medical College
Krakow, Poland, 31-202